miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene

Abstract

This study investigated the effects of miRNA-155 on malignant biological characteristics of NK/T-cell lymphoma cell lines and the possible mechanism. The expression of miRNA-155 was detected in lymphoma cell lines from different sources (SNK-6, YTS, Jurkat and DOHH2) by real-time PCR. Lentiviral vectors (pLL3.7) that could overexpress or downexpress miRNA-155 were constructed. Recombinant lentiviral particles were prepared and purified, and their titers determined. The expression of miRNA-155 in the infected SNK-6 cells and the cell proliferation were detected by PCR and CCK-8, respectively. Flow cytometry was used to determine the apoptosis of infected SNK-6 cells. The target of miRNA155 was predicted from Targetscan website. The effect of miRNA155 on FOXO3a expression was examined by Western blotting. The results showed that among the human NK/T-cell lymphoma cell lines SNK-6, YTS, Jurkat and DOHH2, the expression of miRNA-155 was highest in SNK-6. The infection efficiency of the recombinant lentivirus in SNK-6 was more than 70% at multiplicity of infection (MOI) of 100. The expression of miRNA-155 was significantly increased in SNK-6 cells infected by lentivirus vectors with high expression of miRNA-155 (4 times higher than the control group), and profoundly decreased in those infected with lentiviruses with low expression of miRNA-155. The proliferation of letivirus-infected SNK-6 cells was decreased as the expression of miRNA-155 reduced. The apoptosis rate was increased with the reduction in the expression of miRNA-155. FOXO3a was found to be a possible target of miRNA155, as suggested by Targetscan website. Western blotting showed that the expression of FOXO3a was significantly elevated in SNK-6 cells with miRNA-155 inhibition. It was concluded that reduction in miRNA-155 expression can inhibit the proliferation of SNK-6 lymphoma cells and promote their apoptosis, which may be associated with regulation of FOXO3a gene.

Keywords

miRNA-155 / lentiviral vector / NK/T-cell lymphoma / cell lines / apoptosis / FOXO3a

References

[1] ZhouH, HuangX, CuiH, et al. . miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood, 2010, 116(26): 5885-5894 PMID: 20852130

[2] YaoR, MaYL, LiangW, et al. . MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One, 2012, 7(10): e46082 PMCID: 3473054 PMID: 23091595

[3] LawrieCH, GalS, DunlopHM, et al. . Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol, 2008, 141(5): 672-675 PMID: 18318758

[4] KluiverJ, PoppemaS, de JongD, et al. . BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol, 2005, 207(2): 243-249 PMID: 16041695

[5] HuangX, ShenY, LiuM, et al. . Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. Am J Pathol, 2012, 181(1): 26-33 PMCID: 3388146 PMID: 22609116

[6] TThompsonRC, HerscovitchM, ZhaoI, et al. . NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. J Biol Chem, 2011, 286(3): 1675-1682

[7] KluiverJ, HaralambievaE, de JongD, et al. . Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer, 2006, 45(2): 147-153 PMID: 16235244

[8] SaitoY, SuzukiH, TsugawaH, et al. . Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One, 2012, 7(11): e47396 PMCID: 3509063 PMID: 23209550

[9] MitchellPS, ParkinRK, KrohEM, et al. . Circulating microRNAs as stable blood-based markers for cancer detection. PNAS, 2008, 105(30): 10 513-10 518

[10] WangY, LiJ, TongL, et al. . The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol, 2013, 43(8): 813-820 PMID: 23817461

[11] TangJ, AhmadA, SarkarFH. The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci, 2012, 13(10): 13 414-13 437

[12] LiK. The role of microRNAs in development of natural killer T (NKT) cells, 2010, Xi’an, The Fourth Military Medical University

[13] YamanakaY, TagawaH, TakahashiN, et al. . Aberrant overexpression of microRNAs activates AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood, 2009, 114(15): 3265-3275 PMID: 19641183

[14] ChenTD. MicroRNA-155 expression in renal clear cell carcinoma and influence on biological characteristics of human caucasian kidney adenocarcinoma ACHN, 2011, Changsha, Central South University

[15] AnastasovN, KlierM, KochI, et al. . Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J Hematop, 2009, 2(1): 9-19 PMCID: 2713496 PMID: 19669218

[16] PedersenIM, OteroD, KaoE, et al. . Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med, 2009, 1(5): 288-295 PMCID: 2771872 PMID: 19890474

[17] KongW, HeL, CoppolaM, et al. . MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem, 2010, 285(23): 17869-17879 PMCID: 2878550 PMID: 20371610

[18] JiangS, ZhangHW, LuMH, et al. . MicroRNA-155 functions as an oncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 2010, 70(8): 3119-3127 PMID: 20354188

[19] IkedaJ, TianT, WangY, et al. . Expression of FoxO3a in clinical cases of malignant lymphoma. Pathol Res Pract, 2013, 209(11): 716-720 PMID: 24021689

[20] PathaniaD, SechiM, PalombaM, et al. . Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. Biochim Biophys Acta, 2014, 1840(1): 332-343 PMID: 23954204

[21] HuangL, WangHY, LiJD, et al. . KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Cell Death Dis, 2013, 4(8): e745 PMCID: 3763430 PMID: 23907459

[22] RaiD, KimSW, McKellerMR, et al. . Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci USA, 2010, 107(7): 3111-3116 PMCID: 2840369 PMID: 20133617